These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 21699469)

  • 21. Nitric oxide affects serum ferritin levels in children with iron deficiency.
    Odemis E; Koca C; Karadag A; Catal F; Aydin M; Turkay S; Yigitoglu R
    Pediatr Hematol Oncol; 2007; 24(3):189-94. PubMed ID: 17454788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitrite plasma levels in type 1 and 2 diabetics with and without complications.
    Ferlito S; Gallina M
    Minerva Endocrinol; 1999; 24(3-4):117-21. PubMed ID: 10953727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitrite plasma levels in type 1 and 2 diabetics with and without complications.
    Ferlito S; Gallina M
    Panminerva Med; 1998 Dec; 40(4):304-8. PubMed ID: 9973826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of anticancer drugs on levels of nitric oxide and adrenomedullin.
    Güler E; Balat A; Cekmen M; Kilinç M; Sivasli E; Yürekli M; Duman C
    Turk J Pediatr; 2006; 48(3):202-8. PubMed ID: 17172062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B-type natriuretic peptide as a marker for cardiac dysfunction in anthracycline-treated children.
    Aggarwal S; Pettersen MD; Bhambhani K; Gurczynski J; Thomas R; L'Ecuyer T
    Pediatr Blood Cancer; 2007 Nov; 49(6):812-6. PubMed ID: 17171687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin converting enzyme inhibitors may be protective against cardiac complications following anthracycline chemotherapy.
    Blaes AH; Gaillard P; Peterson BA; Yee D; Virnig B
    Breast Cancer Res Treat; 2010 Jul; 122(2):585-90. PubMed ID: 20058065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adrenomedullin and nitrite levels in children with dilated cardiomyopathy.
    Kilinç M; Balat A; Cekmen M; Yürekli M; Yilmaz K; Sahinöz S
    Pediatr Cardiol; 2003; 24(4):381-5. PubMed ID: 12522650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma nitric oxide levels used as an indicator of doxorubicin-induced cardiotoxicity in rats.
    Guerra J; De Jesus A; Santiago-Borrero P; Roman-Franco A; Rodríguez E; Crespo MJ
    Hematol J; 2005; 5(7):584-8. PubMed ID: 15692604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late doxorubicin-associated cardiotoxicity in children. The possible role of intercurrent viral infection.
    Ali MK; Ewer MS; Gibbs HR; Swafford J; Graff KL
    Cancer; 1994 Jul; 74(1):182-8. PubMed ID: 8004574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective Effects of Dexrazoxane against Doxorubicin-Induced Cardiotoxicity: A Metabolomic Study.
    QuanJun Y; GenJin Y; LiLi W; YongLong H; Yan H; Jie L; JinLu H; Jin L; Run G; Cheng G
    PLoS One; 2017; 12(1):e0169567. PubMed ID: 28072830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum biomarkers for the detection of cardiac toxicity after chemotherapy and radiation therapy in breast cancer patients.
    Tian S; Hirshfield KM; Jabbour SK; Toppmeyer D; Haffty BG; Khan AJ; Goyal S
    Front Oncol; 2014; 4():277. PubMed ID: 25346912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms.
    Quốc Lu'o'ng KV; Nguyễn LT
    Cancer Manag Res; 2012; 4():431-45. PubMed ID: 23293538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].
    Elbl L; Vásová I; Krejcí M; Navrátil M; Tomásková I; Jedlicka F; Chaloupka V; Mayer J; Vorlícek J
    Vnitr Lek; 2006 Mar; 52(3):221-31. PubMed ID: 16722153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum carnitine levels during the doxorubicin therapy. Its role in cardiotoxicity.
    Yaris N; Ceviz N; Coskun T; Akytüz C; Büyükpamukçu M
    J Exp Clin Cancer Res; 2002 Jun; 21(2):165-70. PubMed ID: 12148572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac troponin I: is it a marker to detect cardiotoxicity in children treated with doxorubicin?
    Köseoğlu V; Berberoğlu S; Karademir S; Kismet E; Yurttutan N; Demirkaya E; Sungur M; Alehan D
    Turk J Pediatr; 2005; 47(1):17-22. PubMed ID: 15884624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitrite plasma levels in acute and chronic coronary heart disease.
    Ferlito S; Gallina M
    Minerva Cardioangiol; 1997 Nov; 45(11):553-8. PubMed ID: 9549288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitric oxide: a new biomarker of Doxorubicin toxicity in children?
    Guler E; Baspinar O; Cekmen M; Kilinc M; Balat A
    Pediatr Hematol Oncol; 2011 Aug; 28(5):395-402. PubMed ID: 21699469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paradoxical inhibition of cardiac lipid peroxidation in cancer patients treated with doxorubicin. Pharmacologic and molecular reappraisal of anthracycline cardiotoxicity.
    Minotti G; Mancuso C; Frustaci A; Mordente A; Santini SA; Calafiore AM; Liberi G; Gentiloni N
    J Clin Invest; 1996 Aug; 98(3):650-61. PubMed ID: 8698856
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.